Micrima has been innovating and developing the use of wholly novel Radiowave technology, for use in the detection of breast cancer for the best part of 20 years. I joined Micrima in January 2021 with a remit to commercial the businesses 7th generation MARIA breast imaging device. In the summer of 2022 I led the leadership team, board and investors through a change of direction where we looked to utilise this 20 years of technology development in different way. Focusing on measurement of breast tissue properties (instead of imaging) enabled the device to be significantly reduced in size and become something portable that can be used inside and outside of a hospital environment. What's more it provides pre-imaging breast tissue measurement information that can not only help clinicians chose the best method of detecting a patients breast cancer but also help with inclusion of breast tissue properties in existing breast cancer risk models. The new device does uses non ionising radio waves and not x-rays and as such can be used in pretty much any location and by any user (subject to around 30 minutes of training). This opens up the ability for the device to be used in community settings and even operated by members of the community, where this is preferable. All of these factors help to unlock the potential of personalised breast cancer pathways that drive screening to be based on individual risk (and not general statistics) and also enable patients to have the most appropriate imaging technique, to detect cancer in their particular breast tissue type, first time.At Micrima I have the honour and pleasure to lead a team of incredible people all focused on helping clinicians to detect more instances of breast cancer earlier. I set business strategy by trying to align our technological sweet spots with market problems and work hard to build relationships with the market, teams and investors that are all key to ensuring a successful strategy and plan.

Full Strategic and Financial ownership of the FUJIFILM Medical Systems business in the UK and Ireland with a remit to deliver significant growth in market share, reputation and performance. Initial focus on restructuring the team and re-defining the business culture and go to market strategy. Significant growth delivered through organic growth, partnership and lobbying activity.

Overall responsibility for all products within the FUJIFILM Medical Systems portfolio from order acquisition through to on-going service.

Deliver significant order growth to FUJIFILM's medical systems portfolio in the UK.

• Management of the UKIs Healthcare IT Services team including P&L ownership• Transformation of the Service team to align with the market post exit from the NHS National Program for IT (NPfIT)

• Take financial and strategic ownership for development of Managed and Multi Vendor service as a new profit centre and business line for the business. Help the business understand where they are and develop/implement a strategy for significant growth,• Develop, market, sell and deliver new product/s, developing in to new business opportunity for the company. Delivered strategy, new products and first two major wins within six months.

• Management, Strategy and Provision of operations for Southern England through a team of sales, service centre and field service engineers - including team managers and leaders• Ownership of regional EBITA • Transformation and invigoration of sales and service teams in to combined regional, customer facing teams.

Manage delivery of service to Philips Healthcare's Diagnostic Imaging Equipment customers in the South West and South Central SHAs along with South Wales.

Oversee CS commercial operations globally - including development, marketing and tools for development of CS business through direct sales and agents.

Oversee and manage technical Support activity within North America for Oxford Instruments Plasma Technology business- Based in Concord Massachusetts.

Provide Factory Technical assistance and support to Oxford Instruments global pool of engineers and agents. Remit to reduce global support costs through an increased first time fix rate, stock and supply of the most appropriate spare parts and providing team access the most effective information and tools. During my time in this role I also developed customer first line engineering training courses involving a mix of interactive, work instruction and instructional video.

Travel globally assisting global service teams and agents with capacity issues and complex fixes of Oxford Instruments Plasma, Ion Bean and Molecular Beam Epitaxy equipment

I set up my own company providing contract engineers to LTU airline at Dusseldorf airport. Company provided engineers to assist with increases in engineering demand for rectification and modification work outside of the summer holiday periods. This provided the airline with flexibility to resource it's busy maintenance schedule periods, without compromising strict German employment laws.